Compare ADMA Biologics Inc (ADMA) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? ADMA Biologics Inc trades at $9.18 (market cap $2.13B), while Direxion Daily Semiconductor Bear 3X Shares trades at $4.57. The key difference: ADMA Biologics Inc is trading nearer its 52-week high, Direxion Daily Semiconductor Bear 3X Shares nearer its low. Which is the better fit depends on your goals.
| ADMA | SOXS | |
|---|---|---|
Market Cap | $2.13B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $20.38 | $160.60 |
52-Week Low | $7.60 | $3.25 |
Enterprise Value | $2.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
SOXS, the Direxion Daily Semiconductor Bear 3X Shares ETF, is trading at $4.17, down 7.54% over the past 24 hours. The technical outlook is bearish, with moving averages signaling a downtrend and oscillators neutral. A 1-for-10 stock split is scheduled for July 15, 2026. Recent news highlights the ETF's role in betting against the semiconductor sector amid a historic AI-driven chip rally, with SOXS down 88% over six months as of May 2026.
The outlook for SOXS remains highly risky due to its inverse leveraged structure and the strong bullish trend in semiconductors. Investment opportunity exists solely for tactical, short-term traders seeking to profit from potential sector pullbacks, but risks of significant losses are elevated if the rally persists. Long-term investors should avoid due to volatility decay and structural drawbacks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
